Keros Therapeutics Inc

Keros Therapeutics Inc

KROS

Market Cap$2.55B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Keros Therapeutics IncKeros Therapeutics Inc-13.5--34%--
$101.00

Target Price by Analysts

48.7% upsideKeros Therapeutics Target Price DetailsTarget Price
$10.75

Current Fair Value

84.2% downside

Overvalued by 84.2% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.55 Billion
Enterprise Value$2.04 Billion
Dividend Yield$0 (0%)
Earnings per Share$-5.2
Beta1.24
Outstanding Shares36,103,187

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-13.5
PEG-39.4
Price to Sales-
Price to Book Ratio4.85
Enterprise Value to Revenue3128.61
Enterprise Value to EBIT-10.28
Enterprise Value to Net Income-12
Total Debt to Enterprise0.01
Debt to Equity0.04

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Keros Therapeutics Inc